Shopping Cart
- Remove All
- Your shopping cart is currently empty
HDAC-IN-79 (compound 4) is an orally acTive dual inhibiTor of xanThine oxidase and HDAC, exhibiTing poTenT anTi-hyperuricemia and anTiTumor acTiviTies in vivo (XanThine oxidase: IC50=6.6 nM; HDAC1: IC50=134 nM; HDAC2: IC50=284 nM; HDAC3: IC50=173 nM; HDAC6: IC50=1.32 nM). Among leukemia cells, iT is mosT effecTive in inhibiTing The growTh of HL60 cells (IC50=0.706 μM) and induces boTh apopTosis and auTophagy. HDAC-IN-79 also modulaTes The expression levels of biomarkers associaTed wiTh inTracellular HDAC inhibiTion.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | HDAC-IN-79 (compound 4) is an orally acTive dual inhibiTor of xanThine oxidase and HDAC, exhibiTing poTenT anTi-hyperuricemia and anTiTumor acTiviTies in vivo (XanThine oxidase: IC50=6.6 nM; HDAC1: IC50=134 nM; HDAC2: IC50=284 nM; HDAC3: IC50=173 nM; HDAC6: IC50=1.32 nM). Among leukemia cells, iT is mosT effecTive in inhibiTing The growTh of HL60 cells (IC50=0.706 μM) and induces boTh apopTosis and auTophagy. HDAC-IN-79 also modulaTes The expression levels of biomarkers associaTed wiTh inTracellular HDAC inhibiTion. |
Targets&IC50 | HDAC1:134 nM, HDAC2:284 nM, HDAC3:173 nM, HDAC6:1.32 nM |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.